NCT01114256

FNA Tumor Sampling for CD137 Modulation: A Pilot Study

• Status: Terminated
• Phase: —
• Study type: Observational
• Enrollment: 83 (actual)
• Sponsor: Stanford University · Academic / Other
• Sex: All
• Age: 21 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to better understand the biology of the body's immune response to monoclonal antibody therapy for cancer. Your health information will be used to identify your tissues. The tissue we obtain may be useful for research or education, resulting in new drugs, therapies or diagnostic procedures.

Conditions

• Head and Neck Cancer
• Breast Cancer
• Head and Neck Cancers
• Non-Hodgkin Lymphoma
• Colorectal Adenocarcinoma

Interventions

Type	Name	Description
PROCEDURE	FNA Biopsy

Timeline

• Start date: 2010-03-01
• Primary completion: 2016-01-01
• Completion: 2016-01-01
• First posted: 2010-05-03
• Last updated: 2017-08-03

Locations

1 site across 1 country: United States